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There have been a number of reports on the effect 
of diabetes induced by alloxan on the transport of 
sugars by rat small intestine [l-6] . The interpretation 
of these reports has been complicated by the toxic 
side effects and metabolic disturbances associated 
with the use of alloxan [7]. In the present studies, 
insulin deficiency was induced by the injection (65 
mg/kg body weight, i.v.), one week before the experi- 
ment, of the diabetogenic antibiotic streptozotocin 
[8] , or by the injection (i.v.) of 1 ml anti-insulin- 
serum [9], one hour before the experiment. Everted 
sacs were prepared from the upper and terminal ileum 
of normal and insulin deficient rats (280-320 g) by 
the method of Wilson and Wiseman [lo]. The sacs 
(6 from each region) were filled to a standard isten- 
sion with Krebs Henseleit [1 l] bicarbonate buffer 
(pH 7.4) containing lucose (approx. 1 mg/ml) and 
each was incubated in 10 ml of the same medium in a 
50 ml conical flask. The medium, cooled in ice, was 
kept gassed with 95% 02 and 5%‘C02 prior to the 
experiment. The flasks were stoppered and shaken 
for 30 min at 37’C. The sacs were then removed, 
blotted, and opened, and their contents (serosal fluid) 
and the incubating media (mucosal fluid) analysed for 
glucose by a modified glucose oxidase method [ 121. 
Blood glucose levels in insulin deficient animals 
used for experiment were all above 250 mg/lOO ml. 
In some of the experiments with these animals, insulin 
(100 mu/ml) was added to both the mucosal and 
serosal fluid of alternate sacs in each region prior to 
incubation. 
In the following discussion, it is assumed that the 
development of a final concentration ratio of greater 
than unity is evidence for the presence of an active 
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process of sugar absorption [131. Insulin deficiency 
increased the final concentration ratio of glucose 
developed by sacs in both regions. In the case of the 
upper ileum, these results agree with those reported 
for alloxan induced diabetes [l-6] . The effect was 
particularly apparent in the terminal ileum, where 
ratios significantly greater than one were obtained, 
whereas normally sacs from this region are incapable 
of accumulating glucose against i s concentration 
gradient [141. 
Jervis and Levin [IS] found that the hyperphagia 
of chronic alloxan diabetes in rats, induced an in- 
crease in the size and weight of the intestine at 6-l 2 
months. Increased sugar transport might arise under 
these conditions as a result of intestinal hypertrophy 
but this possibility is precluded in the present expeii- 
ments with anti-insulin-serum, since rats were used 
only one hour after injection. Insulin at high concen- 
tration (100 mu/ml) in the incubating media failed 
to restore the transport of glucose to normal, so 
confirming the findings of Aulsebrook [6] with intes- 
tine of alloxan diabetic rats. This failure was particu- 
larly striking in the terminal ileum rendered insulin 
deficient with anti-insulin-serum, where the induced 
final concentration ratios of greater than unity, were 
unaffected by the presence of insulin. It is possible 
that the insulin molecule is unable to penetrate the 
epithelial cell or that in doing so, it is hydrolysed by 
the endogenous proteolytic enzymes. Alternatively 
the observed effects of insulin deficiency on active 
transport may arise from secondary metabolic dis- 
turbances involving the energy supply for transport 
processes in the small intestine. It is concluded that 
the absorption of glucose by rat small intestine, in 
193 
Volume 2, number 3 FEBS LETTERS January 1969 
Table 1 
Effect of insulin deficiency on the transport of glucose by sacs of everted rat small intestine. 
Terminal ileum 
Normal 
Streptozotocin diabetes 
Streptozotocin control minus insulin 
Streptozotocln plus insulin (in vitro) 
Initial concn. 
of glucose in 
both serosal 
and mucosal 
fluids (mM) 
5.89 
5.89 
6.22 
6.22 
Final concn. 
of glucose 
in serosal 
fluid (mM) 
4.34 + 0.26 
8.01 f0.27 
7.34 f0.18 
7.84 It 0.30 
Final concn. 
of glucose 
in muc0aa.l 
fluid (mM) 
5.38 fO.10 
5.57 + 0.07 
5.97 +0.16 
5.87 f 0.18 
Glucose final 
concentration 
ratio 
(seroaal/mucosal) 
0.80 f0.04 (24) 
* 1.45 f0.06 (35) 
* 1.24 f 0.06 (6) 
* 1.34 f 0.04 (6) 
Anti-insulin-serum control minus insulin 5.71 6.29 f 0.43 5.33 + 0.09 * 1.18 + 0.08 (12) 
Anti-insulin-serum plus insulin (in vitro) 5.71 6.50 + 0.51 5.13 + 0.08 * 1.27 f 0.10 (12) 
Upper ileum 
Normal 
Streptozotocin diabetes 
Streptozotocin control minus insulin 
Streptozotocin plus insulin (in vitro) 
Anti-insulin-serum 
6.07 7.75 + 0.21 4.43 + 0.10 1.71+ 0.04 (24) 
6.92 11.20 kO.41 4.39 +0.13 * 2.55 + 0.08 (18) 
6.22 10.7 1 f 0.67 5.16 f 0.20 * 2.08 f 0.01 (6) 
6.22 11.38 f-O.38 5.41 f0.18 * 2.10 + 0.03 (6) 
6.28 9.60 ? 0.29 4.34 f 0.12 * 2.22 + 0.07 (11) 
Values are + S.E.M. with the number of sacs in parentheses. * denotes P values GO.05 compared with normal intestine. 
Sac length about 3 cm. Initial serosal volume 0.5-1.0 ml. Initial mucosal volume 10 ml. Gas phase 95% 02 and 5% COa. Incuba- 
tion period 30 min, temperature 37°C. 70 oscillations/min, amplitude 5 cm. Initial glucose seroaal/mucosal concentration ratio 
was 1.00. 
vitro, is stimulated in experimental insulin deficiency. 
Studies are in progress to elucidate the mechanism of 
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[4] R.K.Crane, Biochem. Biophys. Res. Commun. 4 (1961) 
this stimulatory response. 436. 
[5] S.D.Varma and S.Banejee, Indian J. Med. Res. 51 
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